GlobalData on MSN
Silver Creek’s stroke hopeful yields mixed results in Phase II trial
If approved, the targeted IGF-1 fusion protein would become the only treatment available for late-window stroke patients ...
11d
Silver Creek Pharmaceuticals Announces Positive Phase 2 Results for Scp776 in Acute Ischemic Stroke
Key Highlights Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up to 24 hours after ...
Nurses on the stroke/neurovascular unit at Providence St. Vincent Medical Center (PSVMC) in Portland, OR, care for approximately 500 stroke patients per year. Nursing staff members used the standard ...
Thorough neurological assessment of patients experiencing acute stroke is critical for accurate diagnosis, treatment, and care throughout hospitalization. Published guidelines for the early management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback